HomeBLRX • TLV
add
BioLine RX Ltd
Previous close
ILA 18.70
Day range
ILA 19.00 - ILA 19.30
Year range
ILA 14.70 - ILA 70.00
Market cap
62.44M USD
Avg Volume
716.22K
P/E ratio
-
Dividend yield
-
Primary exchange
TLV
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2024info | Y/Y change |
|---|---|---|
Revenue | 6.86M | — |
Operating expense | 10.22M | 15.42% |
Net income | -696.00K | 94.28% |
Net profit margin | -10.15 | — |
Earnings per share | — | — |
EBITDA | -3.92M | 54.34% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 28.17M | -34.92% |
Total assets | 51.60M | -24.83% |
Total liabilities | 38.54M | 30.50% |
Total equity | 13.06M | — |
Shares outstanding | 1.09B | — |
Price to book | 18.70 | — |
Return on assets | -20.87% | — |
Return on capital | -49.02% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2024info | Y/Y change |
|---|---|---|
Net income | -696.00K | 94.28% |
Cash from operations | -14.11M | -76.01% |
Cash from investing | 16.69M | 151.23% |
Cash from financing | -894.00K | -1,724.49% |
Net change in cash | 1.74M | 214.07% |
Free cash flow | -12.97M | -145.74% |
About
BioLineRx Ltd., or BioLine, is a publicly traded drug development company. Headquartered in Israel, its shares are traded on the NASDAQ Capital Market and on the Tel Aviv Stock Exchange. Wikipedia
Founded
2003
Website
Employees
79
